Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Schimmer

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Leukocyte Biology|March 21, 1998
Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell wallsD J Schrier, R C Schimmer, C M Flory, et al.
American Journal of Respiratory Cell and Molecular Biology|December 1, 2001
Hypoxia mediates increased neutrophil and macrophage adhesiveness to alveolar epithelial cellsB Beck-Schimmer, R C Schimmer, C Madjdpour, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 27, 1998
Characterization of rat lung ICAM-1B Beck-Schimmer, R C Schimmer, H Schmal, et al.
Clinical and Experimental Immunology|July 6, 2005
Hypoxia aggravates lipopolysaccharide-induced lung injuryD Vuichard, M T Ganter, R C Schimmer, et al.
The European Respiratory Journal|July 11, 2002
Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammationB Beck-Schimmer, C Madjdpour, S Kneller, et al.
Bone|May 4, 2004
Efficacy and safety of ibandronate given by intravenous injection once every 3 monthsS Adami, D Felsenberg, C Christiansen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 17, 2004
Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE studyR R Recker, R S Weinstein, C H Chesnut, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 22, 2002
Decreased alveolar oxygen induces lung inflammationC Madjdpour, U R Jewell, S Kneller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 9, 2004
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE studyP D Delmas, R R Recker, C H Chesnut, et al.
Bone|May 4, 2004
Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosisR Recker, J A Stakkestad, C H Chesnut, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Leukocyte Biology|March 21, 1998
Role of chemokines and cytokines in a reactivation model of arthritis in rats induced by injection with streptococcal cell wallsD J Schrier, R C Schimmer, C M Flory, et al.
American Journal of Respiratory Cell and Molecular Biology|December 1, 2001
Hypoxia mediates increased neutrophil and macrophage adhesiveness to alveolar epithelial cellsB Beck-Schimmer, R C Schimmer, C Madjdpour, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 27, 1998
Characterization of rat lung ICAM-1B Beck-Schimmer, R C Schimmer, H Schmal, et al.
Clinical and Experimental Immunology|July 6, 2005
Hypoxia aggravates lipopolysaccharide-induced lung injuryD Vuichard, M T Ganter, R C Schimmer, et al.
The European Respiratory Journal|July 11, 2002
Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammationB Beck-Schimmer, C Madjdpour, S Kneller, et al.
Bone|May 4, 2004
Efficacy and safety of ibandronate given by intravenous injection once every 3 monthsS Adami, D Felsenberg, C Christiansen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 17, 2004
Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE studyR R Recker, R S Weinstein, C H Chesnut, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 22, 2002
Decreased alveolar oxygen induces lung inflammationC Madjdpour, U R Jewell, S Kneller, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|April 9, 2004
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE studyP D Delmas, R R Recker, C H Chesnut, et al.
Bone|May 4, 2004
Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosisR Recker, J A Stakkestad, C H Chesnut, et al.
Pageof 3